Background, outcome, and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT)

American Journal of Cardiology

Volumn 80, Issue 5 B, 1997, Pages

  Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SOTALOL;

ADULT; AGED; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SUDDEN DEATH; SURVIVAL; TREATMENT OUTCOME;

EID: 0030812828     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00475-X     Document Type: Conference Paper

References (14)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
2. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
3. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation. 69:1984;250-258.
4. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients randomized to receive encainide, flecainide, or placebo in the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 324:1991;781-788.
5. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiologic testing and nonsustained ventricular tachycardia: use and limitation in patients with coronary artery disease and impaired ventricular function. Circulation. 82:1990;350-358.
6. Multicenter Automatic Defibrillator Implantation Trial (MADIT): design and clinical protocol. PACE. 14:1991;920-927.
7. Cox DR. Regression models and life-tables. J R Stat Soc B. 34:1972;187-220.
8. Wever E, Hauer R, Van Capelle F, Tijssen J, Crijns H, Algra A, Wiesfeld A, Bakker P, Pobles de Medina E. Randomized study of implantable defibrillators as first-choice therapy versus conventional strategy in post-infarction sudden death survivors. Circulation. 91:1995;2195-2203.
9. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
10. Camm J. The European Myocardial Infarction Amiodarone Trial (EMIAT): preliminary results presented orally at the American College of Cardiology Meeting, March 1996, Orlando, Florida.
11. Connolly SJ. The Canadian Myocardial Infarction Amiodarone Trial (CAMIAT): preliminary results presented orally at the American College of Cardiology Meeting, March 1996, Orlando, Florida.
12. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 344:1994;493-498.
13. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, Ayduszynski A, Maciejewicz J, Zaleska T, Lazarczyk-Kedzia E, Motyka J, Paczkowska B, Sczaniecka O, Yusuf S. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol. 20:1992;1056-1062.
14. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 65:1982;457-464.